TMCO4
gene geneOn this page
Also known as DKFZp686C23231
Summary
TMCO4 (transmembrane and coiled-coil domains 4, HGNC:27393) is a protein-coding gene on chromosome 1p36.13, encoding Transmembrane and coiled-coil domain-containing protein 4 (Q5TGY1).
Predicted to be located in membrane.
Source: NCBI Gene 255104 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 145 total
- MANE Select transcript:
NM_181719
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:27393 |
| Approved symbol | TMCO4 |
| Name | transmembrane and coiled-coil domains 4 |
| Location | 1p36.13 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | DKFZp686C23231 |
| Ensembl gene | ENSG00000162542 |
| Ensembl biotype | protein_coding |
| Entrez | 255104 |
Gene structure
Transcript identifiers
Ensembl transcripts: 70 — 64 protein_coding, 6 protein_coding_CDS_not_defined
ENST00000294543, ENST00000375127, ENST00000462171, ENST00000488449, ENST00000489135, ENST00000489814, ENST00000494342, ENST00000496528, ENST00000866952, ENST00000866953, ENST00000866954, ENST00000866955, ENST00000866956, ENST00000866957, ENST00000866958, ENST00000866959, ENST00000866960, ENST00000866961, ENST00000866962, ENST00000866963, ENST00000866964, ENST00000866965, ENST00000866966, ENST00000866967, ENST00000866968, ENST00000866969, ENST00000866970, ENST00000866971, ENST00000866972, ENST00000866973, ENST00000866974, ENST00000866975, ENST00000866976, ENST00000866977, ENST00000866978, ENST00000866979, ENST00000866980, ENST00000866981, ENST00000866982, ENST00000866983, ENST00000866984, ENST00000866985, ENST00000866986, ENST00000866987, ENST00000929250, ENST00000962042, ENST00000962043, ENST00000962044, ENST00000962045, ENST00000962046, ENST00000962047, ENST00000962048, ENST00000962049, ENST00000962050, ENST00000962051, ENST00000962052, ENST00000962053, ENST00000962054, ENST00000962055, ENST00000962056, ENST00000962057, ENST00000962058, ENST00000962059, ENST00000962060, ENST00000962061, ENST00000962062, ENST00000962063, ENST00000962064, ENST00000962065, ENST00000962066
RefSeq mRNA: 5 — MANE Select: NM_181719
NM_001349112, NM_001349113, NM_001349114, NM_001349115, NM_181719
CCDS: CCDS198
Canonical transcript exons
ENST00000294543 — 16 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001066123 | 19745532 | 19745651 |
| ENSE00001353498 | 19787026 | 19787117 |
| ENSE00001372579 | 19799855 | 19799916 |
| ENSE00001376551 | 19798137 | 19798215 |
| ENSE00001856944 | 19682240 | 19683444 |
| ENSE00003507233 | 19770542 | 19770569 |
| ENSE00003565615 | 19747163 | 19747260 |
| ENSE00003576628 | 19700768 | 19700885 |
| ENSE00003590095 | 19746456 | 19746599 |
| ENSE00003603268 | 19694434 | 19694551 |
| ENSE00003608817 | 19771308 | 19771482 |
| ENSE00003622849 | 19740777 | 19740941 |
| ENSE00003630185 | 19739824 | 19739960 |
| ENSE00003638641 | 19737372 | 19737456 |
| ENSE00003672467 | 19780580 | 19780766 |
| ENSE00003692252 | 19755634 | 19755766 |
Expression profiles
Bgee: expression breadth ubiquitous, 207 present calls, max score 90.52.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 2.7793 / max 34.5363, expressed in 1365 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 10688 | 2.3567 | 1262 |
| 10686 | 0.1570 | 76 |
| 10689 | 0.1378 | 39 |
| 10687 | 0.0805 | 40 |
| 10690 | 0.0473 | 21 |
Top tissues by expression
258 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| lower esophagus mucosa | UBERON:0035834 | 90.52 | gold quality |
| sural nerve | UBERON:0015488 | 88.82 | gold quality |
| granulocyte | CL:0000094 | 88.28 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 88.09 | gold quality |
| metanephros cortex | UBERON:0010533 | 87.58 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 87.55 | gold quality |
| prostate gland | UBERON:0002367 | 87.49 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 87.40 | gold quality |
| thyroid gland | UBERON:0002046 | 87.10 | gold quality |
| body of pancreas | UBERON:0001150 | 87.02 | gold quality |
| body of stomach | UBERON:0001161 | 86.89 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 86.79 | gold quality |
| pancreatic ductal cell | CL:0002079 | 86.75 | silver quality |
| left adrenal gland | UBERON:0001234 | 86.72 | gold quality |
| right adrenal gland | UBERON:0001233 | 86.70 | gold quality |
| corpus epididymis | UBERON:0004359 | 86.69 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 86.69 | gold quality |
| right uterine tube | UBERON:0001302 | 86.42 | gold quality |
| minor salivary gland | UBERON:0001830 | 86.05 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 85.80 | gold quality |
| popliteal artery | UBERON:0002250 | 85.53 | gold quality |
| adrenal cortex | UBERON:0001235 | 85.50 | gold quality |
| duodenum | UBERON:0002114 | 85.50 | gold quality |
| tibial artery | UBERON:0007610 | 85.50 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 85.49 | gold quality |
| adrenal gland | UBERON:0002369 | 85.34 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 85.17 | gold quality |
| aorta | UBERON:0000947 | 85.01 | gold quality |
| stomach | UBERON:0000945 | 84.98 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 84.66 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.69 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
27 targeting TMCO4, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-126-5P | 100.00 | 72.71 | 3180 |
| HSA-MIR-4778-3P | 99.93 | 70.40 | 1818 |
| HSA-MIR-137-3P | 99.87 | 74.74 | 2401 |
| HSA-MIR-4755-5P | 99.71 | 70.34 | 2716 |
| HSA-MIR-5006-3P | 99.71 | 70.26 | 2728 |
| HSA-MIR-7-5P | 99.67 | 70.53 | 1809 |
| HSA-MIR-6833-5P | 99.50 | 68.93 | 1161 |
| HSA-MIR-584-3P | 99.35 | 67.69 | 1082 |
| HSA-MIR-6804-3P | 98.72 | 64.82 | 852 |
| HSA-MIR-6868-3P | 98.63 | 69.64 | 2259 |
| HSA-MIR-4700-5P | 98.63 | 67.43 | 1915 |
| HSA-MIR-4436B-3P | 98.25 | 65.26 | 1494 |
| HSA-MIR-6735-5P | 98.24 | 65.36 | 1488 |
| HSA-MIR-5691 | 98.23 | 67.02 | 1335 |
| HSA-MIR-6805-3P | 98.23 | 67.02 | 1334 |
| HSA-MIR-6826-3P | 98.19 | 66.32 | 1153 |
| HSA-MIR-7843-5P | 98.12 | 65.26 | 1421 |
| HSA-MIR-4632-5P | 97.82 | 65.38 | 1470 |
| HSA-MIR-6879-5P | 97.77 | 65.52 | 1521 |
| HSA-MIR-8089 | 97.74 | 66.21 | 1698 |
| HSA-MIR-4667-5P | 97.61 | 66.67 | 1683 |
| HSA-MIR-4308 | 97.56 | 67.13 | 1385 |
| HSA-MIR-558 | 97.50 | 67.16 | 977 |
| HSA-MIR-4456 | 97.50 | 64.88 | 1678 |
| HSA-MIR-541-3P | 96.07 | 66.11 | 1271 |
| HSA-MIR-654-5P | 96.07 | 66.18 | 1280 |
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | tmco4 | ENSDARG00000078924 |
| mus_musculus | Tmco4 | ENSMUSG00000041143 |
| rattus_norvegicus | Tmco4 | ENSRNOG00000017401 |
| caenorhabditis_elegans | WBGENE00018044 |
Protein
Protein identifiers
Transmembrane and coiled-coil domain-containing protein 4 — Q5TGY1 (reviewed: Q5TGY1)
All UniProt accessions (2): A0A075B6H3, Q5TGY1
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Membrane.
Similarity. Belongs to the TMCO4 family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q5TGY1-1 | 1 | yes |
| Q5TGY1-2 | 2 |
RefSeq proteins (5): NP_001336041, NP_001336042, NP_001336043, NP_001336044, NP_859070* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR007941 | DUF726 | Family |
| IPR029058 | AB_hydrolase_fold | Homologous_superfamily |
Pfam: PF05277
UniProt features (11 total): transmembrane region 3, sequence variant 2, chain 1, sequence conflict 1, region of interest 1, coiled-coil region 1, compositionally biased region 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5TGY1-F1 | 73.10 | 0.44 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 56 (showing top):
FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN, ROZANOV_MMP14_TARGETS_UP, LIAO_METASTASIS, chr1p36, MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED, WHITFIELD_CELL_CYCLE_G2_M, WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D, ESC_V6.5_UP_EARLY.V1_UP, CHAF1B_TARGET_GENES, DLX6_TARGET_GENES, DMRT1_TARGET_GENES, FOXD2_TARGET_GENES, NKX2_2_TARGET_GENES, SFMBT1_TARGET_GENES, TERF1_TARGET_GENES
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (1): membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
300 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TMCO4 | FAM187B | Q17R55 | 621 |
| TMCO4 | ETDA | Q3ZM63 | 575 |
| TMCO4 | VPS29 | Q9UBQ0 | 510 |
| TMCO4 | OR4F16 | Q6IEY1 | 505 |
| TMCO4 | LENG9 | Q96B70 | 419 |
| TMCO4 | SERPINI1 | Q99574 | 414 |
| TMCO4 | MSTO1 | Q9BUK6 | 412 |
| TMCO4 | UBXN10 | Q96LJ8 | 400 |
| TMCO4 | GIMAP8 | Q8ND71 | 388 |
| TMCO4 | SIL1 | Q9H173 | 387 |
| TMCO4 | C5orf58 | C9J3I9 | 364 |
| TMCO4 | GALNT9 | Q9HCQ5 | 359 |
| TMCO4 | FAM8A1 | Q9UBU6 | 356 |
| TMCO4 | PSD3 | Q9NYI0 | 347 |
| TMCO4 | EML1 | O00423 | 346 |
IntAct
13 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TMCO4 | VPS29 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KPTN | EIF4G3 | psi-mi:“MI:0914”(association) | 0.530 |
| PGRMC1 | psi-mi:“MI:0914”(association) | 0.350 | |
| BVLF1 | VWA8 | psi-mi:“MI:0914”(association) | 0.350 |
| KPTN | ALDH1A2 | psi-mi:“MI:0914”(association) | 0.350 |
| SLC37A3 | PLXNB2 | psi-mi:“MI:0914”(association) | 0.350 |
| FLT1 | MTCL2 | psi-mi:“MI:0914”(association) | 0.350 |
| VPS29 | TMCO4 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (19): TMCO4 (Affinity Capture-MS), TMCO4 (Affinity Capture-MS), TMCO4 (Affinity Capture-RNA), TMCO4 (Affinity Capture-MS), TMCO4 (Two-hybrid), TMCO4 (Proximity Label-MS), TMCO4 (Proximity Label-MS), TMCO4 (Proximity Label-MS), TMCO4 (Proximity Label-MS), TMCO4 (Proximity Label-MS), TMCO4 (Proximity Label-MS), TMCO4 (Affinity Capture-MS), TMCO4 (Affinity Capture-MS), TMCO4 (Proximity Label-MS), TMCO4 (Proximity Label-MS)
ESM2 similar proteins: A0JMH2, A1L251, A2ARP1, A7Z050, D3ZEY4, E7FCP8, E9QAM5, O00562, O35954, O42412, O95822, P0C644, P0C7A1, P12617, P16386, P40935, P49898, P49899, P52824, P53370, P54310, P70563, Q17QN2, Q2KI24, Q3URQ7, Q499U8, Q5EU90, Q5I0I8, Q5RAR6, Q5RDF1, Q5TGY1, Q5U2N3, Q5XIL6, Q68J42, Q6P5E8, Q6PD24, Q6PFW1, Q80YU0, Q8BX80, Q8CH40
Diamond homologs: O14244, P43564, Q10SS2, Q499U8, Q5TGY1, Q91WU4, Q9US10, Q20035
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
145 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 114 |
| Likely benign | 7 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2591 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:19694430:TCA:T | donor_loss | 1.0000 |
| 1:19694431:CA:C | donor_loss | 1.0000 |
| 1:19694432:A:AC | donor_gain | 1.0000 |
| 1:19694432:A:T | donor_loss | 1.0000 |
| 1:19694432:AC:A | donor_gain | 1.0000 |
| 1:19694433:C:CA | donor_gain | 1.0000 |
| 1:19694433:CC:C | donor_gain | 1.0000 |
| 1:19694433:CCA:C | donor_gain | 1.0000 |
| 1:19694433:CCACA:C | donor_gain | 1.0000 |
| 1:19694547:CTCCC:C | acceptor_gain | 1.0000 |
| 1:19694549:CCC:C | acceptor_gain | 1.0000 |
| 1:19694550:CC:C | acceptor_gain | 1.0000 |
| 1:19694550:CCC:C | acceptor_gain | 1.0000 |
| 1:19694551:CC:C | acceptor_gain | 1.0000 |
| 1:19694552:C:A | acceptor_loss | 1.0000 |
| 1:19694552:C:CC | acceptor_gain | 1.0000 |
| 1:19694554:G:C | acceptor_gain | 1.0000 |
| 1:19700741:C:A | donor_gain | 1.0000 |
| 1:19700763:CAGA:C | donor_loss | 1.0000 |
| 1:19700764:AGAC:A | donor_loss | 1.0000 |
| 1:19700765:GAC:G | donor_loss | 1.0000 |
| 1:19700767:C:CG | donor_loss | 1.0000 |
| 1:19700886:C:CC | acceptor_gain | 1.0000 |
| 1:19737367:CTCA:C | donor_loss | 1.0000 |
| 1:19737368:TCA:T | donor_loss | 1.0000 |
| 1:19737369:CA:C | donor_loss | 1.0000 |
| 1:19737370:A:C | donor_loss | 1.0000 |
| 1:19737371:C:CA | donor_loss | 1.0000 |
| 1:19737371:CCTTT:C | donor_gain | 1.0000 |
| 1:19737452:CGCCC:C | acceptor_gain | 1.0000 |
AlphaMissense
4065 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:19737424:G:C | S404R | 0.998 |
| 1:19737424:G:T | S404R | 0.998 |
| 1:19737426:T:G | S404R | 0.998 |
| 1:19739852:A:G | L384P | 0.998 |
| 1:19746581:G:T | A211D | 0.998 |
| 1:19740882:A:G | W313R | 0.997 |
| 1:19740882:A:T | W313R | 0.997 |
| 1:19740924:A:G | W299R | 0.997 |
| 1:19740924:A:T | W299R | 0.997 |
| 1:19746569:A:T | V215D | 0.997 |
| 1:19747183:A:T | V198D | 0.997 |
| 1:19747189:G:T | A196E | 0.997 |
| 1:19737431:C:T | G402D | 0.996 |
| 1:19739861:C:T | G381D | 0.996 |
| 1:19739876:C:G | R376P | 0.996 |
| 1:19740878:T:A | E314V | 0.996 |
| 1:19746566:G:T | A216D | 0.996 |
| 1:19747195:C:T | G194D | 0.996 |
| 1:19737397:A:C | C413W | 0.995 |
| 1:19739895:A:G | W370R | 0.995 |
| 1:19739895:A:T | W370R | 0.995 |
| 1:19739948:G:T | A352D | 0.995 |
| 1:19745555:C:T | G285E | 0.995 |
| 1:19745612:A:G | F266S | 0.995 |
| 1:19746500:G:T | A238D | 0.995 |
| 1:19747177:C:T | G200D | 0.995 |
| 1:19694495:G:T | A480D | 0.994 |
| 1:19694546:T:A | D463V | 0.994 |
| 1:19700777:C:T | G458D | 0.994 |
| 1:19700820:A:G | W444R | 0.994 |
dbSNP variants (sampled 300 via entrez): RS1000003725 (1:19681952 C>T), RS1000035066 (1:19681984 G>T), RS1000045182 (1:19758499 C>G), RS1000050094 (1:19761295 C>A,G,T), RS1000057358 (1:19722229 A>T), RS1000074882 (1:19701657 C>A), RS1000075237 (1:19776152 C>G,T), RS1000086732 (1:19681752 C>T), RS1000117437 (1:19757152 G>A,T), RS1000120755 (1:19720254 C>T), RS1000172095 (1:19782025 A>G), RS1000178024 (1:19791078 T>C), RS1000210539 (1:19698549 G>A,T), RS1000224458 (1:19781863 G>A), RS1000236056 (1:19704511 A>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST003815_97 | Late-onset Alzheimer’s disease | 7.000000e-06 |
| GCST007565_50 | Morning person | 3.000000e-15 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:1001870 | late-onset Alzheimers disease |
| EFO:0008328 | chronotype measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
24 total (human), top 24 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | increases expression, affects cotreatment | 3 |
| Benzo(a)pyrene | decreases expression, increases methylation | 2 |
| beta-lapachone | decreases expression | 1 |
| sodium arsenite | increases expression | 1 |
| zinc chromate | decreases expression, increases abundance | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| chromium hexavalent ion | increases abundance, decreases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, increases expression | 1 |
| abrine | decreases expression | 1 |
| dorsomorphin | affects cotreatment, increases expression | 1 |
| jinfukang | increases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Air Pollutants | affects expression, increases abundance | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Ozone | increases abundance, affects expression | 1 |
| Testosterone | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Urethane | decreases expression | 1 |
| 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | decreases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Cadmium Chloride | increases abundance, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.